Examqo › Examqo library › Radiology › Genitourinary and pelvic imaging · IMLE
Prostate MRI and PI-RADS
In PI-RADS 2.1 the deciding sequence in the peripheral zone is DWI and in the transition zone T2, dynamic enhancement only upgrades a score of 3 to 4 in the peripheral zone, and a score of 4–5 leads to targeted biopsy.
Why it matters in the exam
Pre-biopsy multiparametric MRI is now recommended in a man with suspected prostate cancer: it detects clinically significant cancer and guides targeted biopsy. The 1–5 score expresses the likelihood of significant cancer. In the peripheral zone, where most tumours arise, the dominant sequence is DWI and ADC; in the transition zone the dominant sequence is T2, because benign hyperplasia confounds diffusion. Positive dynamic enhancement (DCE) upgrades a lesion from score 3 to score 4 in the peripheral zone only. A peripheral zone tumour appears as a dark focus on T2 with restricted diffusion; in the transition zone — a dark T2 focus "like erased charcoal" with ill-defined margins.
After biopsy, wait at least 6 weeks before MRI, because haemorrhage disturbs reading. Extraprostatic extension is sought on T2: capsular bulge, irregularity, a long tumour–capsule contact (above about 15 mm) and obliteration of the rectoprostatic angle. Seminal vesicle invasion: low T2 signal within the vesicles, restricted diffusion, and spread along the ejaculatory duct. With a normal MRI or a score of 1–2 and a low PSA density, avoiding biopsy may be considered.
Staging: PSMA PET-CT is preferred over CT and bone scan in high risk to detect lymph nodes and metastases. Active surveillance uses repeated MRI. Bladder cancer: MRI with the VI-RADS score assesses muscle invasion. Testicular tumour: after US, CT of the chest, abdomen and pelvis for staging — retroperitoneal nodes around the renal vessels are the first station. A man with high PSA and a palpable nodule still needs biopsy regardless of MRI.
Key points
- Peripheral — DWI; transition — T2.
- DCE upgrades 3 to 4 only in the peripheral zone.
- PI-RADS 4–5 — targeted biopsy.
- 6 weeks after biopsy before MRI.
- PSMA PET-CT for staging in high risk.
Summary table
| Zone | Dominant sequence | Tumour appearance | Note |
|---|---|---|---|
| Peripheral | DWI and ADC | Dark T2 focus with restricted diffusion | Positive DCE upgrades 3 to 4 |
| Transition | T2 | Erased charcoal, ill-defined margins | Benign hyperplasia confounds diffusion |
| Extraprostatic extension | T2 | Bulge, contact longer than 15 mm, obliterated angle | Changes stage |
| Seminal vesicles | T2 and DWI | Low signal in the vesicle | Stage T3b |
| After biopsy | — | Haemorrhage | Wait at least 6 weeks |
In the full version for subscribers
- A simple algorithm
- Memory aid
- Exam traps
- 5 review cards
- Enough for IMLE
The full version is open to subscribers of: Diagnostic radiology, Medical licensing exam (IMLE), General surgery.
Subscriber? Read the full topic Plans and prices 25 free questions
Sources
- ACR–ESUR–AdMeTech PI-RADS, version 2.1 (2019) — Dominant sequences and assessment categories
- EAU–EANM–ESTRO–ESUR–ISUP–SIOG Guidelines on Prostate Cancer, 2024 — Pre-biopsy MRI
Sources are given for further reading; the text is written afresh and not copied from them.
Reviewed by the Examqo AI Professor · 2026-11-06. The text may contain errors; when in doubt, check the source.
See also: Localised prostate cancer